| A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: an introductory review H Askari, SF Rajani, M Poorebrahim, H Haghi-Aminjan, ... Pharmacological research 129, 44-55, 2018 | 206 | 2018 |
| Selenium stimulates the antitumour immunity: Insights to future research A Razaghi, M Poorebrahim, D Sarhan, M Björnstedt European Journal of Cancer 155, 256-267, 2021 | 170 | 2021 |
| Mechanisms of antigen escape from BCMA-or GPRC5D-targeted immunotherapies in multiple myeloma H Lee, S Ahn, R Maity, N Leblay, B Ziccheddu, M Truger, M Chojnacka, ... Nature medicine 29 (9), 2295-2306, 2023 | 157 | 2023 |
| Counteracting CAR T cell dysfunction M Poorebrahim, J Melief, Y Pico de Coaña, S L. Wickström, A Cid-Arregui, ... Oncogene 40 (2), 421-435, 2021 | 130 | 2021 |
| Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects M Poorebrahim, S Sadeghi, E Fakhr, MF Abazari, V Poortahmasebi, ... Critical reviews in clinical laboratory sciences 56 (6), 393-419, 2019 | 84 | 2019 |
| TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential M Poorebrahim, N Mohammadkhani, R Mahmoudi, M Gholizadeh, ... Cancer gene therapy 28 (6), 581-589, 2021 | 54 | 2021 |
| The role of nitric oxide signaling in renoprotective effects of hydrogen sulfide against chronic kidney disease in rats: Involvement of oxidative stress, autophagy and apoptosis MK Shirazi, A Azarnezhad, MF Abazari, M Poorebrahim, P Ghoraeian, ... Journal of cellular physiology 234 (7), 11411-11423, 2019 | 51 | 2019 |
| Nanosized aptameric cavities imprinted on the surface of magnetic nanoparticles for high-throughput protein recognition E Shoghi, SZ Mirahmadi-Zare, R Ghasemi, M Asghari, M Poorebrahim, ... Microchimica Acta 185, 1-11, 2018 | 39 | 2018 |
| Appraisal of role of the polyanionic inducer length on amyloid formation by 412-residue 1N4R Tau protein: A comparative study A Jangholi, MR Ashrafi-Kooshk, SS Arab, G Riazi, F Mokhtari, ... Archives of Biochemistry and Biophysics 609, 1-19, 2016 | 31 | 2016 |
| Impacts of the G145R mutation on the structure and immunogenic activity of the hepatitis B surface antigen: a computational analysis R Rezaee, M Poorebrahim, S Najafi, S Sadeghi, A Pourdast, SM Alavian, ... Hepatitis monthly 16 (7), 2016 | 31 | 2016 |
| Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals I Quiros-Fernandez, M Poorebrahim, E Fakhr, A Cid-Arregui EBioMedicine 72, 2021 | 29 | 2021 |
| HBsAg mutations related to occult hepatitis B virus infection in HIV‐positive patients result in a reduced secretion and conformational changes of HBsAg A Sadeghi, E Shirvani‐Dastgerdi, F Tacke, E Yagmur, V Poortahmasebi, ... Journal of medical virology 89 (2), 246-256, 2017 | 29 | 2017 |
| Genetically modified immune cells targeting tumor antigens M Poorebrahim, MF Abazari, S Sadeghi, R Mahmoudi, A Kheirollahi, ... Pharmacology & therapeutics 214, 107603, 2020 | 26 | 2020 |
| Recombinant immunotoxins development for HER2-based targeted cancer therapies R Mahmoudi, H Dianat-Moghadam, M Poorebrahim, S Siapoush, ... Cancer cell international 21, 1-17, 2021 | 25 | 2021 |
| How hepatitis C virus leads to hepatocellular carcinoma: A network-based study V Poortahmasebi, M Poorebrahim, S Najafi, SM Jazayeri, SM Alavian, ... Hepatitis monthly 16 (2), 2016 | 21 | 2016 |
| Rational design of DKK3 structure-based small peptides as antagonists of Wnt signaling pathway and in silico evaluation of their efficiency M Poorebrahim, S Sadeghi, H Rahimi, M Karimipoor, K Azadmanesh, ... PLoS One 12 (2), e0172217, 2017 | 20 | 2017 |
| In silico enhancement of the stability and activity of keratinocyte growth factor M Poorebrahim, S Sadeghi, R Ghorbani, M Asghari, MF Abazari, H Kalhor, ... Journal of theoretical biology 418, 111-121, 2017 | 18 | 2017 |
| Integrated epigenetic and transcriptional single-cell analysis of t (11; 14) multiple myeloma and its BCL2 dependency N Leblay, S Ahn, R Tilmont, M Poorebrahim, R Maity, H Lee, E Barakat, ... Blood 143 (1), 42-56, 2024 | 16 | 2024 |
| Immunomodulatory effects of a rationally designed peptide mimetic of human IFNβ in EAE model of multiple sclerosis M Poorebrahim, M Asghari, MF Abazari, H Askari, S Sadeghi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 82, 49-61, 2018 | 15 | 2018 |
| Update on immune‐based therapy strategies targeting cancer stem cells A Izadpanah, N Mohammadkhani, M Masoudnia, M Ghasemzad, ... Cancer Medicine 12 (18), 18960-18980, 2023 | 13 | 2023 |